Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 22

Sort by

Sort Order Select

Journal Articles

DICE: Transcriptomic Profiling and Analysis of Impact of Genetic Variation on Rare Immune Cell Populations

Benjamin J Schmiedel, Zubin Roy, Vicente Fajardo Rosas, Cristian Gonzalez-Colin, Job Rocha, Pandurangan Vijayanand

Blood (2024) 144 (Supplement 1): 122.

https://doi.org/10.1182/blood-2024-201665

Published: 2024

Journal Articles

Activation-Induced Release of the TNF-Family Member BAFF By NK Cells Facilitates Resistance of Chronic Lymphoid Leukemia Cells to Direct and Rituximab-Induced NK Lysis

Julia S Wild, Stefanie Raab, MSc, Benjamin J Schmiedel, PhD, Andreas Maurer, Pascal Schneider, PhD, Lothar Kanz, MD, Helmut R Salih, MD

Blood (2014) 124 (21): 1963.

https://doi.org/10.1182/blood.V124.21.1963.1963

Published: 2014

Journal Articles

The Role of Her2/Neu in ALL: Long Term Clinical Follow-up of Surface-Positive Patients and Induction of NK Cell ADCC by Trastuzumab in Vitro

Sebastian P. Haen, Benjamin J Schmiedel, PhD, Nora Roth, Christoph Faul, MD, Robert Möhle, Marc Schmalzing, MD, Lothar Kanz, MD, Wichard Vogel, MD, Helmut R Salih, MD

Blood (2012) 120 (21): 1421.

https://doi.org/10.1182/blood.V120.21.1421.1421

Published: 2012

Journal Articles

Induction of NK Cell Reactivity in Breast Cancer by Fc-Engineered NKG2D-Ig Fusion Proteins

Stefanie Raab, Julia Steinbacher, Ludger Grosse-Hovest, PhD, Benjamin J Schmiedel, PhD, Alexander Steinle, PhD, Lothar Kanz, MD, Helmut R Salih, MD

Blood (2012) 120 (21): 253.

https://doi.org/10.1182/blood.V120.21.253.253

Published: 2012

Journal Articles

Induction of NK Cell Reactivity Against AML Cells by Fc-Engineered RANK-Ig Fusion Proteins.

Tina Nuebling, PhD, Benjamin J Schmiedel, PhD, Miyuki Azuma, MD, PhD, Pascal Schneider, PhD, Ludger Grosse-Hovest, PhD, Lothar Kanz, MD, Helmut R Salih, MD

Blood (2012) 120 (21): 2625.

https://doi.org/10.1182/blood.V120.21.2625.2625

Published: 2012

Journal Articles

The Role of OX40 and Its Ligand in Acute Myeloid Leukemia: Expression, Function and Modulation of NK Cell Anti-Leukemia Reactivity

Carla E Schumacher, Tina Nuebling, PhD, Martin Hofmann, Benjamin J Schmiedel, PhD, Lothar Kanz, MD, Gundram Jung, MD, Helmut R Salih, MD

Blood (2012) 120 (21): 3548.

https://doi.org/10.1182/blood.V120.21.3548.3548

Published: 2012

Journal Articles

Involvement of NFAT Signaling in Function and Anti-Tumor Reactivity of NK Cells

Julia S Wild, Benjamin J Schmiedel, PhD, Melanie Märklin, Lothar Kanz, MD, Martin R Müller, MD, PhD, Helmut R Salih, MD

Blood (2012) 120 (21): 1887.

https://doi.org/10.1182/blood.V120.21.1887.1887

Published: 2012

Journal Articles

Bimodal Induction of NK Cell Reactivity Against Acute Myeloid (AML) and Chronic Lymphoid Leukemia (CLL) by Fc-Engineered GITR-Fc Fusion Proteins.

Julia Steinbacher, Benjamin J Schmiedel, PhD, Antje Werner, Tina Nuebling, PhD, Corina Buechele, Ludger Grosse-Hovest, PhD, Lothar Kanz, MD, Helmut R Salih, MD

Blood (2012) 120 (21): 2143.

https://doi.org/10.1182/blood.V120.21.2143.2143

Published: 2012

Journal Articles

Expression and Immunomodulatory Function of RANKL in Leukemia

Benjamin J Schmiedel, Tina Baessler, Miyuki Azuma, Lothar Kanz, MD, Helmut R. Salih, MD

Blood (2011) 118 (21): 245.

https://doi.org/10.1182/blood.V118.21.245.245

Published: 2011

Journal Articles

Targeting RANKL for Immunotherapy of Multiple Myeloma

Benjamin J Schmiedel, Ludger Grosse-Hovest, Stefanie Bugl, M. Sc., Hans-Georg Kopp, MD, Stefan Wirths, MD, Bernd J Pichler, Miyuki Azuma, Pascal Schneider, Lothar Kanz, MD, Gundram Jung, Helmut R. Salih, MD

Blood (2011) 118 (21): 2905.

https://doi.org/10.1182/blood.V118.21.2905.2905

Published: 2011

Journal Articles

Fc-Engineered NKG2D-IgG1 Fusion Proteins Target Leukemia Cells for Antibody-Dependent Cellular Cytotoxicity (ADCC) of NK Cells

Julia Hilpert, Katrin Baltz-Ghahremanpour, Benjamin J Schmiedel, Lothar Kanz, MD, Gundram Jung, Ludger Grosse-Hovest, Helmut R. Salih, MD

Blood (2011) 118 (21): 1537.

https://doi.org/10.1182/blood.V118.21.1537.1537

Published: 2011

Journal Articles

Fc-Engineered RANK-Fc Fusion Proteins for Neutralization of Soluble RANKL and Induction of Antibody-Dependent Cellular Cytotoxicity (ADCC) Against Multiple Myeloma

Benjamin J Schmiedel, Carolin Scheible, Tina Baessler, Constantin M Wende, Stefan Wirths, Miyuki Azuma, Pascal Schneider, Ludger Grosse-Hovest, Lothar Kanz, Helmut R Salih

Blood (2010) 116 (21): 3039.

https://doi.org/10.1182/blood.V116.21.3039.3039

Published: 2010

Journal Articles

RANKL Expressed by Acute Myeloid Leukemia Cells Impairs NK Cell-Mediated Immune Surveillance

Benjamin J Schmiedel, Constantin M Wende, Tina Baessler, Carolin Scheible, Stefan Wirths, Miyuki Azuma, Pascal Schneider, Ludger Grosse-Hovest, Lothar Kanz, Helmut R Salih

Blood (2010) 116 (21): 2164.

https://doi.org/10.1182/blood.V116.21.2164.2164

Published: 2010

Journal Articles

4-1BB Ligand Mediates a “Vicious Cycle” of Immune Evasion Upon Reciprocal Interaction of Chronic Lymphocytic Leukemia and NK Cells

Corina Buechele, Tina Baessler, Benjamin J Schmiedel, Lothar Kanz, MD, Helmut R. Salih, MD

Blood (2010) 116 (21): 2416.

https://doi.org/10.1182/blood.V116.21.2416.2416

Published: 2010

Journal Articles

A Fc-Engineered RANK-Fc Fusion Protein Neutralizes Soluble RANK Ligand and Targets Malignant Hematopoietic Cells for NK Cell Reactivity.

Benjamin J Schmiedel, Tina Baessler, Carolin Scheible, Constantin M Wende, Miyuki Azuma, Pascal Schneider, Lothar Kanz, MD, Ludger Grosse-Hovest, Helmut R Salih, MD

Blood (2009) 114 (22): 411.

https://doi.org/10.1182/blood.V114.22.411.411

Published: 2009

Journal Articles

Glucocorticoid-Induced TNFR-Related Protein (GITR) Ligand Mediates Tumor Immunoediting in Chronic Lymphocytic Leukemia and Impairs Direct and Rituximab-Induced NK Cell Anti-Leukemia Reactivity.

Corina Buechele, Tina Baessler, Benjamin J Schmiedel, Lothar Kanz, MD, Helmut R Salih, MD

Blood (2009) 114 (22): 4403.

https://doi.org/10.1182/blood.V114.22.4403.4403

Published: 2009

Journal Articles

Consequences of 4-1BB-4-1BB Ligand Interaction for NK Cell Anti-Tumor Immunity: Opposite Effects of Seemingly Analogue Molecules in Mice and Men.

Tina Baessler, Jean E Charton, Corina Buechele, Benjamin J Schmiedel, Frank Gruenebach, Matthias Krusch, MD, Alexander Wacker, Lothar Kanz, MD, Helmut R Salih, MD

Blood (2009) 114 (22): 279.

https://doi.org/10.1182/blood.V114.22.279.279

Published: 2009

Journal Articles

NK Cell Anti-Tumor Reactivity Is Impaired by Platelet-Derived TGF-B through NKG2D Downregulation

Hans-Georg Kopp, Theresa Placke, Benjamin J Schmiedel, Lothar Kanz, MD, Matthias Krusch, Helmut R Salih, MD

Blood (2008) 112 (11): 2859.

https://doi.org/10.1182/blood.V112.11.2859.2859

Published: 2008

Journal Articles

The Role of CD137 and Its Ligand in Chronic Lymphocytic Leukemia (CLL)

Tina Baessler, Corina Buechele, Matthias Krusch, Benjamin J Schmiedel, Lothar Kanz, Helmut R Salih

Blood (2008) 112 (11): 3130.

https://doi.org/10.1182/blood.V112.11.3130.3130

Published: 2008

Journal Articles

5-Azacytosine (Azacytidine) and 2′-Deoxy-5-Azacytidine (Decitabine) Mediate Opposite Effects on NK Cell Anti-Tumor Reactivity

Benjamin J Schmiedel, Viktor Arélin, Matthias Krusch, Lothar Kanz, Helmut R Salih

Blood (2008) 112 (11): 2626.

https://doi.org/10.1182/blood.V112.11.2626.2626

Published: 2008

NARROW

DICE: Transcriptomic Profiling and Analysis of Impact of Genetic Variation on Rare Immune Cell Populations

Activation-Induced Release of the TNF-Family Member BAFF By NK Cells Facilitates Resistance of Chronic Lymphoid Leukemia Cells to Direct and Rituximab-Induced NK Lysis

The Role of Her2/Neu in ALL: Long Term Clinical Follow-up of Surface-Positive Patients and Induction of NK Cell ADCC by Trastuzumab in Vitro

Induction of NK Cell Reactivity in Breast Cancer by Fc-Engineered NKG2D-Ig Fusion Proteins

Induction of NK Cell Reactivity Against AML Cells by Fc-Engineered RANK-Ig Fusion Proteins.

The Role of OX40 and Its Ligand in Acute Myeloid Leukemia: Expression, Function and Modulation of NK Cell Anti-Leukemia Reactivity

Involvement of NFAT Signaling in Function and Anti-Tumor Reactivity of NK Cells

Bimodal Induction of NK Cell Reactivity Against Acute Myeloid (AML) and Chronic Lymphoid Leukemia (CLL) by Fc-Engineered GITR-Fc Fusion Proteins.

Expression and Immunomodulatory Function of RANKL in Leukemia

Targeting RANKL for Immunotherapy of Multiple Myeloma

Fc-Engineered NKG2D-IgG1 Fusion Proteins Target Leukemia Cells for Antibody-Dependent Cellular Cytotoxicity (ADCC) of NK Cells

Fc-Engineered RANK-Fc Fusion Proteins for Neutralization of Soluble RANKL and Induction of Antibody-Dependent Cellular Cytotoxicity (ADCC) Against Multiple Myeloma

RANKL Expressed by Acute Myeloid Leukemia Cells Impairs NK Cell-Mediated Immune Surveillance

4-1BB Ligand Mediates a “Vicious Cycle” of Immune Evasion Upon Reciprocal Interaction of Chronic Lymphocytic Leukemia and NK Cells

A Fc-Engineered RANK-Fc Fusion Protein Neutralizes Soluble RANK Ligand and Targets Malignant Hematopoietic Cells for NK Cell Reactivity.

Glucocorticoid-Induced TNFR-Related Protein (GITR) Ligand Mediates Tumor Immunoediting in Chronic Lymphocytic Leukemia and Impairs Direct and Rituximab-Induced NK Cell Anti-Leukemia Reactivity.

Consequences of 4-1BB-4-1BB Ligand Interaction for NK Cell Anti-Tumor Immunity: Opposite Effects of Seemingly Analogue Molecules in Mice and Men.

NK Cell Anti-Tumor Reactivity Is Impaired by Platelet-Derived TGF-B through NKG2D Downregulation

The Role of CD137 and Its Ligand in Chronic Lymphocytic Leukemia (CLL)

5-Azacytosine (Azacytidine) and 2′-Deoxy-5-Azacytidine (Decitabine) Mediate Opposite Effects on NK Cell Anti-Tumor Reactivity

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only